Tag : Parkinson’s disease

Clinical Research, Pharma & Healthcare Financing

XellSmart Gets FDA Clearance for 3 Phase I INDs in CNS Cell Therapies

PR Newswire
by PR Newswire083
XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell therapies. To date, the company has...
Clinical Research, Pharma & Healthcare Financing

Newronika Gets FDA IDE for U.S. Trial of Adaptive DBS System

PR Newswire
by PR Newswire0118
Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption (IDE) from the U.S....